3rd Annual Summit on The Evolving Role of Medical Affairs and Thought Leader Engagement

Facutly Interview:

	Tehseen Salimi, MD, MHA Vice President, Global Medical Affairs AstraZeneca
Dr. Tehseen Salimi possesses more than 20 years experience in medical affairs management and is seasoned in developing strategic collaborations within various health care segments. She speaks on the need to build strategic alliances amongst providers, policy makers and patients.
Listen Now!

	Amit Rakhit, MD Senior Vice President, Worldwide Medical Biogen
Dr. Amit Rakhit talks about some of the challenges for all stakeholders in a rapidly evolving environment and how medical affairs organizations are addressing them.
Listen Now!

Just Added:
Opening Address to be delivered by Hospira CVP & CMO!

Stan Bukofzer, MD Corporate Vice President and Chief Medical Officer Hospira

SELECT FROM INTERACTIVE PRE-CONFERENCE WORKSHOPS:

Workshop A: Develop a Medical Strategy that Aligns with Business Goals

	Amit Rakhit, MD Senior Vice President, Worldwide Medical Biogen
	Leon Rozen, MBBS Senior Medical Director Baxter International Inc.
	Liia Vainchtein, PharmD, PhD Senior Director, Head, Global Scientific Strategy, Global Medical Affairs Takeda Pharmaceutical International, Inc.

View workshop details »

Workshop B: Champion Cutting Edge Research - Identify and Access the Right Key Opinion Leaders and Organizations

	Rudy Christian, MPH, DrPH Director, Health Outcomes and Value Assessment Pacira Pharmaceuticals
	Terrie Livingston, PharmD Senior Director, U.S. Medical; Medical and Value Based Outcomes Biogen
	Amy Smalarz, PhD President Strategic Market Insight

View workshop details »

Tightening restrictions and greater transparency as a result of health care reform and the Sunshine Act provide the opportunity for Medical Affairs organizations to play an increasingly pivotal role within the company.

The rapidly evolving environment creates many additional external stakeholders for medical affairs such as payers, integrated delivery networks, professional societies, and other large entities. Medical affairs organizations are enhancing their abilities to identify and access key opinion leaders (KOLs) in those entities as well as work in concert with their internal colleagues. Identifying useful quality metrics to assess the value of the medical affairs department and its activities, as well as communicating that value to key groups are critical components to advance the role that medical affairs teams can play in their organizations.

SUMMIT HIGHLIGHTS:

• Discuss strategies to bring engagement to the next level
• Develop a medical strategy that is aligned with business goals for sustained success
• Identify appropriate thought leaders to engage with to develop mutually strategic relationships
• Measure what matters for MSL metrics to determine internal and external value
• Balance communication demands for real world evidence with unsolicited requests for off-label information

PLUS:

• Hear invaluable insights directly from OIG and the U.S. Attorney's Office to ensure that medical affairs activities are executed in a compliant manner
• Benefit from targeted tracked programming focused on heightening strategies around Global Medical Affairs or Field Team Management

See who attended last year

Sponsorship and Executive Networking Opportunities Available

Contact David Capobianco:
[email protected] or 781-939-2635